Investigator Initiated Clinical Trials
Supports large-scale, investigator-led clinical trials in Denmark to improve patient care through innovative medicines, technologies, and rigorous, transparent clinical research.
Funder: Novo Nordisk Foundation
Due Dates: August 18, 2026
Funding Amounts: DKK 6–22 million per grant (approx. €800,000–€3 million) for 3–5 years; total call budget DKK 89 million
Summary: Supports large, non-commercial clinical trials in Denmark to advance patient care through new medicines, technologies, and high-quality research.
Key Information: Main applicant must be a specialist physician with research leadership, employed at a Danish hospital where the trial is anchored.
Description
This grant supports investigator-initiated, non-commercial clinical trials in Denmark with the goal of improving patient treatment through innovative medicines and technologies. The scheme is intended to foster high-quality, large-scale clinical research that advances clinical medicine and ensures the highest standard of patient care. Both monocentric and multicenter national trials are eligible, as well as international trials anchored in Denmark. The program emphasizes scientific rigor, clinical relevance, adherence to good clinical practice (GCP), and data transparency, including public sharing of anonymized data after trial completion.
